SCHEMBL4748413

SCHEMBL4748413

CN1CCN(c2cccc3c2C[C@H](NC(=O)c2ccc(N4CCCC4)cc2Cl)CO3)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 6/20 0.56
SCN9A Q15858 6/20 0.56
SCN5A Q14524 5/20 0.56
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.42
AVPR2 P30518 2/20 0.41
ALDH1A1 P00352 2/20 0.41
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
P2RX7 Q99572 1/20 0.41
MAPT P10636 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TP53 P04637 1/20 0.39
DRD2 P14416 2/20 0.38
HTR2A P28223 2/20 0.38
DRD3 P35462 2/20 0.38
F9 P00740 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4838400 0.84 KCNH2 (0.70) KCNH2SCN9ASCN5ARAB9ANPC1
SCHEMBL4838380 0.84 KCNH2 (0.70) KCNH2SCN9ASCN5ARAB9ANPC1
SCHEMBL4839237 0.81 KCNH2 (0.55) KCNH2SCN9ASCN5ARAB9ANPC1
SCHEMBL4839223 0.81 KCNH2 (0.55) KCNH2SCN9ASCN5ARAB9ANPC1
SCHEMBL4838319 0.79 KCNH2 (0.70) KCNH2SCN9ASCN5ARAB9ANPC1
SCHEMBL4838340 0.79 KCNH2 (0.70) KCNH2SCN9ASCN5ARAB9ANPC1
SCHEMBL4842018 0.79 KCNH2 (0.70) KCNH2SCN9ASCN5ARAB9ANPC1
SCHEMBL8075560 0.78 KCNH2 (0.61) KCNH2SCN9ASCN5AALDH1A1LMNA
SCHEMBL4830463 0.78 SCN9A (0.66) KCNH2SCN9ASCN5AALDH1A1LMNA
SCHEMBL4830454 0.78 KCNH2 (0.63) KCNH2SCN9ASCN5AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008130322-A1 NOVEL 5-HETEROCYCLYL-CHROMANE DERIVATIVES FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2008-10-30 WO disclosed